SEC 13F Intelligence

ONCOCYTE CORP

CUSIP 68235C107

Oncocyte Corp has 48 institutional holders in Filings Flow’s 13F database, together reporting 54.52M shares worth $16M as of Q4 2022.

Institutional Holders
48
Q4 2022
Reported Value
$16M
Ticker
unmapped
private placement or foreign
Quarters Tracked
7

Ownership Trend

Institutional holders
Q4 ’18: 16Q4 ’18Q1 ’19: 37Q1 ’19Q2 ’19: 39Q2 ’19Q3 ’19: 40Q3 ’19Q2 ’21: 78Q2 ’21Q4 ’21: 76Q4 ’21Q4 ’22: 48Q4 ’22filingsflow.com
Total reported value
Q4 ’18: $11MQ4 ’18Q1 ’19: $57MQ1 ’19Q2 ’19: $31MQ2 ’19Q3 ’19: $34MQ3 ’19Q2 ’21: $276MQ2 ’21Q4 ’21: $192MQ4 ’21Q4 ’22: $16MQ4 ’22filingsflow.com

Holders

Mixed quarters
Export to Excel
Manager% of PortfolioValueSharesQuarter
AWM Investment Company, Inc.$903M AUM0.44%$3M1.10MQ2 2024OLDER
Defender Capital, LLC.$308M AUM0.05%$126,92144.4KQ1 2025

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.